Navigation Links
Alfacell to Present at BIO InvestorForum 2007
Date:10/4/2007

SOMERSET, N.J., Oct. 4 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL) today announced that Lawrence A. Kenyon, executive vice president, chief financial officer and corporate secretary, will present an overview of the company's product development programs at 2 p.m. PDT on Oct. 11th, at BIO InvestorForum 2007 at the Palace Hotel in San Francisco.

A live audio Webcast of the presentation will be available on Alfacell's Web site at http://www.alfacell.com. A replay of the Webcast will be available online for 90 days.

About Alfacell Corporation

Alfacell Corporation is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE(R), is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. In addition to an ongoing Phase IIIb study in malignant mesothelioma, Alfacell is conducting a Phase I/II trial of ONCONASE in non-small cell lung cancer (NSCLC) and other solid tumors. For more information, visit http://www.alfacell.com.

Safe Harbor

This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to s
'/>"/>

SOURCE Alfacell Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... July 28, 2014 Research and Markets ... Synthetic Biology Market 2014-2018" report to their offering. ... The term synthetic biology covers the designing and engineering ... well as the redesigning of natural biological systems that ... be a form of extreme genetic engineering because it ...
(Date:7/28/2014)... & Boston, MA (PRWEB) July 28, 2014 ... agreements with two researchers to further develop potential treatments ... malignant brain tumor, in combination with their patented vaccine ... ITI and Duke University, are based on the work ... Division of Neurosurgery at The Preston Robert Tisch Brain ...
(Date:7/28/2014)... 2014 The global market for biotechnology ... according to a new study by Grand View Research, ... for effective vaccines and drugs in an attempt to ... is expected to drive market demand over the next ... productivity via the use of genetically engineered seeds is ...
(Date:7/28/2014)... The National Model Aviation Museum, located at ... to announce that it has been granted full civilian ... States Air Force. , The certification is the culmination ... spring with an on-site inspection by Sarah Sessions, Museum ... National Museum of the United States Air Force ...
Breaking Biology Technology:Global Synthetic Biology Market 2014-2018 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4AMA’s National Model Aviation Museum Granted Full Civilian Museum Certification by the National Museum of the United States Air Force 2
... revenue growth ... - Product revenues increased 30% to a record $59.7 ... - Shipped 28,600 new pulse oximeters ... increased 104%, IRVINE, Calif., April 29, 2008 Masimo,Corporation (Nasdaq: MASI ), the ...
... to transmit medical images via cellular phones that has ... Jerusalem researcher has the potential to provide sophisticated radiological ... population lacking access to such technology. This would include ... rural areas of developed countries who live considerable distances ...
... /PRNewswire-FirstCall/,-- Shire plc ("Shire") (LSE: SHP, NASDAQ: SHPGY), ... publication of the,Prospectus by Shire Limited on 16 ... to 700,000,000 Ordinary Shares of 5 pence each ... be made available through,publication on Shire,s website: ...
Cached Biology Technology:Masimo Reports First Quarter 2008 Financial Results 2Masimo Reports First Quarter 2008 Financial Results 3Masimo Reports First Quarter 2008 Financial Results 4Masimo Reports First Quarter 2008 Financial Results 5Masimo Reports First Quarter 2008 Financial Results 6Masimo Reports First Quarter 2008 Financial Results 7Masimo Reports First Quarter 2008 Financial Results 8Masimo Reports First Quarter 2008 Financial Results 9Masimo Reports First Quarter 2008 Financial Results 10Researchers develop method for transmitting medical images via cell phones 2Researchers develop method for transmitting medical images via cell phones 3Researchers develop method for transmitting medical images via cell phones 4Publication of Supplementary Prospectus 2Publication of Supplementary Prospectus 3Publication of Supplementary Prospectus 4
(Date:7/28/2014)... Brain & Behavior Research Foundation today announced the ... recognizing exceptional clinical and basic research by young ... Investigator Grants. The grants enable early career scientists ... research for the prevention, early detection, treatment, and ... four people. , Six young scientistswinners of the ...
(Date:7/28/2014)... 15% of adults suffer from fertility problems, many of ... a paradox: We might expect such genes, which reduce ... population. Research at the Weizmann Institute of Science that ... have solved this riddle. Not only can it explain ... open new avenues in understanding the causes of genetic ...
(Date:7/27/2014)... has revealed that nicotine and cotinine, a metabolite of ... certain carcinogen in smoke. , The carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or ... and ultimately ends up in the tobacco smoke. Once ... where it is activated by a variety of enzymes ... revealed that nicotine can partially interfere with the activation ...
Breaking Biology News(10 mins):The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 2The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 3The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 4Mutations from Venus, mutations from Mars 2Nicotine found to inhibit DNA-strand break caused by a certain carcinogen in smoke 2
... forces apparatus and an atomic force microscope, researchers at UC ... interactions, leading to insights into demyelinating diseases, such as multiple ... the National Academy of the Sciences . For a ... nerve cells that run throughout our bodies must be ...
... GA--Managing the quality and quantity of freshwater resources ... of the 21st century. Global population growth and ... water resources among domestic, industrial, and agricultural users. ... while recognizing the limitations of freshwater resources, many ...
... on climate protection and political declarations of intent, ... the contrary, they continue to increase. With a ... markets such as India and China the emission ... to be unlikely. Therefore, large-scale methods to artificially ...
Cached Biology News:Unhealthy attachments 2Unhealthy attachments 3Report details multiple commercial uses of wireless sensor networks 2Climate engineering: Minor potential, major side effects 2Climate engineering: Minor potential, major side effects 3
WTAP Antibody...
Mouse monoclonal to Factor V Heavy Chain Immunogen: Purified human Factor V. Specificity: This antibody reacts with the activation C peptide (mw ~150,000) in the heavy chain of thrombin-cleave...
...
Mouse monoclonal [DJR3] to DcR1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
Biology Products: